Загрузка...
Whole exome sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target
Patients diagnosed with anaplastic large cell lymphoma (ALCL) are still treated with toxic multi-agent chemotherapy and as many as 25-50% of patients relapse. To understand disease pathology and to uncover novel targets for therapy, we performed whole-exome sequencing of anaplastic lymphoma kinase (...
Сохранить в:
| Опубликовано в: : | Haematologica |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Fondazione Ferrata Storti
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8168516/ https://ncbi.nlm.nih.gov/pubmed/32327503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2019.238766 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|